Fast-tracking elastin to market

Prof. Tony Weiss from the University of Sydney in conjunction with Elastagen Pty Ltd has been awarded a $1million Translation Award from the Wellcome Trust to fast track their elastin-based synthetic skin to clinical trials. They will refine and optimise its physical and biological properties so this innovative material can be tested for its safety and efficacy in repairing full thickness skin wounds. They aim to use the mesh to help wounds like those that arise from injury, surgery or disease heal faster and without scarring.

Elastin is the body’s naturally occurring elastic protein and Prof. Weiss and his research group have depended on confocal and scanning electron microscopy in the AMMRF at the University of Sydney to develop and improve their elastin products.

Related Stories
26.10.2017
Microscopy for Medtech

MTPConnect helping us help medtech – Press Release

AMMRF Technical Voucher Fund receives funding from MTPConnect’s Project Fund Program Recognised as a big, bold idea to improve the productivity, competitiveness and innovative capacity of Australia’s medtech, biotech and pharmaceutical ...

11.12.2015
Logo-Hazer

Hazer Group live on ASX

Hazer Group was established in 2010 from technology developed at UWA to produce clean hydrogen and high-grade synthetic graphite from natural gas and iron ore. Its development depended on AMMRF microscopy @ UWA. They have announced the successful ...

02.10.2014
NanopatchInSkin

Nanopatch to tackle polio

The World Health Organization (WHO) is to provide funding to spin-out company, Vaxxas, so it can develop the NanopatchTM for polio vaccination. WHO will fund pre-clinical studies and the development of good manufacturing practices. Following the ...

MORE NEWS...